INCY vs GMAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

INCY

63.9
AI Score
VS
INCY Wins

GMAB

35.3
AI Score

Investment Advisor Scores

INCY

64score
Recommendation
BUY

GMAB

35score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric INCY GMAB Winner
Forward P/E 14.7059 15.083 INCY
PEG Ratio 10.8221 4.3581 GMAB
Revenue Growth 37.7% 24.9% INCY
Earnings Growth 37.7% -9.4% INCY
Tradestie Score 63.9/100 35.3/100 INCY
Profit Margin 27.7% 19.1% INCY
Beta 1.00 1.00 Tie
AI Recommendation BUY AVOID NEW MONEY INCY

Relative Price Performance (Last 90 Days)

INCY 1M: -10.5% · 3M: -0.3% GMAB 1M: +1.6% · 3M: +24.1%

Current Technical Phase

INCY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 34

RSI (14): 33.7 · Price: $115.30

GMAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.9% over 20 days), RSI 57

RSI (14): 56.7 · Price: $34.75

Fundamentals Snapshot

Metric INCY GMAB
Market Cap — —
Forward P/E 13.1 22.7
Trailing P/E 15.5 27.2
Revenue (TTM) — —
Revenue Growth 0.4% 0.2%
Gross Margin 0.6% 0.9%
Operating Margin 0.4% 0.4%
EPS 7.58 1.27
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, INCY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.